Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $8,556 - $10,456
42 Added 1.08%
3,920 $922,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $151,969 - $194,544
742 Added 23.66%
3,878 $794,000
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $1,710 - $2,222
-8 Reduced 0.25%
3,136 $735,000
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $1.66 Million - $1.91 Million
-6,389 Reduced 67.02%
3,144 $829,000
Q4 2021

Feb 15, 2022

BUY
$271.6 - $314.21 $1.74 Million - $2.01 Million
6,395 Added 203.79%
9,533 $3 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $72,827 - $81,710
-265 Reduced 7.79%
3,138 $883,000
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $59,189 - $65,362
-235 Reduced 6.46%
3,403 $939,000
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $46,302 - $57,636
226 Added 6.62%
3,638 $928,000
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $31,027 - $35,593
166 Added 5.11%
3,412 $695,000
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $216,637 - $261,086
1,297 Added 66.55%
3,246 $611,000
Q2 2020

Aug 13, 2020

SELL
$113.31 - $182.44 $29,687 - $47,799
-262 Reduced 11.85%
1,949 $324,000
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $230,651 - $431,764
2,211 New
2,211 $279,000
Q4 2019

Feb 14, 2020

SELL
$163.48 - $173.61 $430,606 - $457,288
-2,634 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$159.77 - $178.1 $1.34 Million - $1.49 Million
-8,356 Reduced 76.03%
2,634 $443,000
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $1.2 Million - $1.44 Million
8,356 Added 317.24%
10,990 $1.9 Million
Q1 2019

May 20, 2019

BUY
$123.7 - $156.3 $325,825 - $411,694
2,634 New
2,634 $403,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.